Adaptability of an Undetectable = Untransmissible Model for HBV
Start Date
5/1/2026
Completion Date
9/1/2027
Summary
Persons with chronic hepatitis B (HBV) infection and active viremia are infectious and may transmit virus to others through blood/body fluid exposure. Immune tolerant treatment naive persons with hepatitis B infection express anxiety regarding disclosure of their infection status and significant fear of transmission to their partners leading to social isolation and impact on their personal lives. This study will provide data correlating serum and body fluid viral levels in persons with chronic hepatitis B infection not on therapy and those with viral suppression on long-term anti-retroviral therapy (ART) that may support the concept of "Undetectable=Untransmissible" (U=U) in patients with chronic hepatitis B.
Eligibility Criteria
Age Range: 18 years to 65 years
Conditions
Locations
NYU Langone Health
New York, New York 10016
United States